Skip to main content
Erschienen in: Abdominal Radiology 5/2006

01.10.2006

Early ovarian cancer: 3-D power Doppler

verfasst von: S. Kupesic, B. M. Plavsic

Erschienen in: Abdominal Radiology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Transvaginal sonography plays an important role in the assessment of the morphology of ovarian lesions. However, the accuracy of the technique is limited due to the significant number of false-positive results. Color Doppler imaging and pulsed Doppler spectral analysis enable evaluation of ovarian tumor blood flow, analysis of the distribution of blood vessels, and quantitative measurement of blood flow velocity waveforms. These parameters increase the sensitivity and specificity of ultrasound evaluation of ovarian tumors. Unfortunately, there is no consensus as to which Doppler parameters and cutoff values are the most predictive of malignancy. Three-dimensional (3-D) power Doppler ultrasound provides a new tool to evaluate features of tumor vascularity. Three-dimensional ultrasound and 3-D power Doppler imaging in patients with “positive” findings on standard ultrasound tests, which encompass annual gray-scale transvaginal sonography followed by transvaginal color Doppler ultrasound in selected cases, represent a novel approach for early and accurate detection of ovarian cancer through screening. Combined evaluations of morphology and neovascularity by 3-D power Doppler ultrasound may improve early detection of ovarian carcinoma. Contrast-enhanced 3-D power Doppler sonography facilitates visualization of adnexal tumor vessels, which may aid in differentiating benign from malignant adnexal lesions.
Literatur
1.
Zurück zum Zitat Law MR, Morris JK, Wald NJ (1999) The importance of age in screening for cancer. J Med Screen 6:16–20PubMed Law MR, Morris JK, Wald NJ (1999) The importance of age in screening for cancer. J Med Screen 6:16–20PubMed
2.
Zurück zum Zitat Jemal A, Tiwari RC, Murray T, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29PubMedCrossRef
3.
Zurück zum Zitat Heintz APM, Odicino F, Maisonneuve P, et al. (2001) Carcinoma of the ovary. 24th Volume of the FIGO Annual Report on the Results of Treatment in Gynecological Cancer. J Epideiol Biostai 6:107–138 Heintz APM, Odicino F, Maisonneuve P, et al. (2001) Carcinoma of the ovary. 24th Volume of the FIGO Annual Report on the Results of Treatment in Gynecological Cancer. J Epideiol Biostai 6:107–138
4.
Zurück zum Zitat Goswamy RK, Campbell S, Whitehead MI (1983) Screening for ovarian cancer. Clin Obstet Gynecol 10:621–643 Goswamy RK, Campbell S, Whitehead MI (1983) Screening for ovarian cancer. Clin Obstet Gynecol 10:621–643
5.
Zurück zum Zitat Campbell S, Bhan V, Royston P, et al. (1989) Transabdominal ultrasound screening for early ovarian cancer. BMJ 299:1363–1367PubMedCrossRef Campbell S, Bhan V, Royston P, et al. (1989) Transabdominal ultrasound screening for early ovarian cancer. BMJ 299:1363–1367PubMedCrossRef
6.
Zurück zum Zitat Kurjak A, Shalan H, Kupesic S, et al. (1994) An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med 13:295–301PubMed Kurjak A, Shalan H, Kupesic S, et al. (1994) An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med 13:295–301PubMed
7.
Zurück zum Zitat Schulman H, Conway C, Zalud I, et al. (1994) Prevalence in a volunteer population of pelvic cancer detected with transvaginal ultrasound and color flow Doppler. Ultrasound Obstet Gynecol 4:414–420PubMedCrossRef Schulman H, Conway C, Zalud I, et al. (1994) Prevalence in a volunteer population of pelvic cancer detected with transvaginal ultrasound and color flow Doppler. Ultrasound Obstet Gynecol 4:414–420PubMedCrossRef
8.
Zurück zum Zitat van Nagell JR, DePriest PD, Reedy MB, et al. (2000) The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 77:350–356PubMedCrossRef van Nagell JR, DePriest PD, Reedy MB, et al. (2000) The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 77:350–356PubMedCrossRef
9.
Zurück zum Zitat Sato S, Yokoyama Y, Sakamoto T, et al. (2000) Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer 89:582–588PubMedCrossRef Sato S, Yokoyama Y, Sakamoto T, et al. (2000) Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer 89:582–588PubMedCrossRef
10.
Zurück zum Zitat Einhorn N, Sjovall P, Knapp RC, et al. (1992) Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 80:14–18PubMed Einhorn N, Sjovall P, Knapp RC, et al. (1992) Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 80:14–18PubMed
11.
Zurück zum Zitat Jacobs IJ, Skates SJ, Macdonald N, et al. (1999) Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353:1207–1210PubMedCrossRef Jacobs IJ, Skates SJ, Macdonald N, et al. (1999) Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353:1207–1210PubMedCrossRef
12.
Zurück zum Zitat Kurjak A, Sparac V, Kupesic S, Bekavac I (2001) Three-dimensional ultrasound and three-dimensional power Doppler in the assessment of adnexal masses. Ultrasound Rev Obset Gynecol 1:167–183CrossRef Kurjak A, Sparac V, Kupesic S, Bekavac I (2001) Three-dimensional ultrasound and three-dimensional power Doppler in the assessment of adnexal masses. Ultrasound Rev Obset Gynecol 1:167–183CrossRef
13.
Zurück zum Zitat Granberg S, Norstrom A, Wikland M (1990) Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 37:224–229PubMedCrossRef Granberg S, Norstrom A, Wikland M (1990) Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 37:224–229PubMedCrossRef
14.
Zurück zum Zitat Benacerraf BR, Finkler NJ, Wojchiechowski C, Knapp RC (1990) Sonographic accuracy in the diagnosis of ovarian masses. J Reprod Med 35:491–495PubMed Benacerraf BR, Finkler NJ, Wojchiechowski C, Knapp RC (1990) Sonographic accuracy in the diagnosis of ovarian masses. J Reprod Med 35:491–495PubMed
15.
Zurück zum Zitat Sassone AM, Timor-Tritch IE, Artner A, et al. (1991) Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 78:70–76PubMed Sassone AM, Timor-Tritch IE, Artner A, et al. (1991) Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 78:70–76PubMed
16.
Zurück zum Zitat Lerner JP, Timor-Tritch IE, Federman A, Abramovich G (1994) Transvaginal sonographic characterization of ovarian masses using an improved, weighted scoring system. Am J Obstet Gynecol 170:81–85PubMed Lerner JP, Timor-Tritch IE, Federman A, Abramovich G (1994) Transvaginal sonographic characterization of ovarian masses using an improved, weighted scoring system. Am J Obstet Gynecol 170:81–85PubMed
17.
Zurück zum Zitat Folkman J, Merler E, Abernathz C, Williams G (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275–288PubMedCrossRef Folkman J, Merler E, Abernathz C, Williams G (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275–288PubMedCrossRef
18.
Zurück zum Zitat Kurjak A, Kupesic S (1995) Transvaginal color Doppler and pelvic tumor angiogenesis: lessons learned and future challenges. Ultrasound Obstet Gynecol 6:145–159PubMedCrossRef Kurjak A, Kupesic S (1995) Transvaginal color Doppler and pelvic tumor angiogenesis: lessons learned and future challenges. Ultrasound Obstet Gynecol 6:145–159PubMedCrossRef
19.
Zurück zum Zitat Kurjak A, Shalan H, Kupesic S, et al. (1993) Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol 3:137–154PubMedCrossRef Kurjak A, Shalan H, Kupesic S, et al. (1993) Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol 3:137–154PubMedCrossRef
20.
Zurück zum Zitat Kurjak A, Kupesic S, Breyer B, et al. (1998) The assessment of ovarian tumor angiogenesis: what does three-dimensional power Doppler add? Ultrasound Obstet Gynecol 12:1–11CrossRef Kurjak A, Kupesic S, Breyer B, et al. (1998) The assessment of ovarian tumor angiogenesis: what does three-dimensional power Doppler add? Ultrasound Obstet Gynecol 12:1–11CrossRef
21.
Zurück zum Zitat Kurjak A, Shalan H, Matijevic R, et al. (1993) Stage I ovarian cancer by transvaginal color Doppler sonography: a report of 18 cases. Ultrasound Obstet Gynecol 3:195–199PubMedCrossRef Kurjak A, Shalan H, Matijevic R, et al. (1993) Stage I ovarian cancer by transvaginal color Doppler sonography: a report of 18 cases. Ultrasound Obstet Gynecol 3:195–199PubMedCrossRef
22.
Zurück zum Zitat Fleischer AC, Cullinan JA, Peery CV, Jones JW III (1996) Early detection of ovarian carcinoma with transvaginal color Doppler ultrasound. Am J Obstet Gynecol 174:101–106PubMedCrossRef Fleischer AC, Cullinan JA, Peery CV, Jones JW III (1996) Early detection of ovarian carcinoma with transvaginal color Doppler ultrasound. Am J Obstet Gynecol 174:101–106PubMedCrossRef
23.
Zurück zum Zitat Downey BD, Fenster A (1995) Vascular imaging with a three-dimensional power Doppler system. AJR 165:665–668PubMed Downey BD, Fenster A (1995) Vascular imaging with a three-dimensional power Doppler system. AJR 165:665–668PubMed
24.
Zurück zum Zitat Cohen LS, Escobar PF, Scharm C, et al. (2001) Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol Oncol 82:40–48PubMedCrossRef Cohen LS, Escobar PF, Scharm C, et al. (2001) Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol Oncol 82:40–48PubMedCrossRef
25.
Zurück zum Zitat Kurjak A, Kupesic S, Sparac V, et al. (2003) The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler. Gynecol Oncol 90:258–264PubMedCrossRef Kurjak A, Kupesic S, Sparac V, et al. (2003) The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler. Gynecol Oncol 90:258–264PubMedCrossRef
26.
Zurück zum Zitat Eltabbakh GH, Yadav PR, Morgan A (1999) Clinical picture of women with early stage ovarian cancer. Gynecol Oncol 75:476–479PubMedCrossRef Eltabbakh GH, Yadav PR, Morgan A (1999) Clinical picture of women with early stage ovarian cancer. Gynecol Oncol 75:476–479PubMedCrossRef
27.
Zurück zum Zitat Sates SJ, Xu FJ, Yu YH, et al. (1995) Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76:2004–2010CrossRef Sates SJ, Xu FJ, Yu YH, et al. (1995) Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76:2004–2010CrossRef
28.
Zurück zum Zitat Menon U, Jacobs IJ (2000) Ovarian cancer screening in the general population. Ultrasound Obstet Gynecol 15:350–353PubMedCrossRef Menon U, Jacobs IJ (2000) Ovarian cancer screening in the general population. Ultrasound Obstet Gynecol 15:350–353PubMedCrossRef
29.
Zurück zum Zitat The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. 2002 ACOG Committee Opinion No. 280. Obstet Gynecol 100:1413–1416 The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. 2002 ACOG Committee Opinion No. 280. Obstet Gynecol 100:1413–1416
30.
Zurück zum Zitat Czekierdowski A, Smolen A, Bednarek W, Kotarski J (2002) Three dimensional sonography and 3-D power Doppler angiography in differentiation of adnexal tumors. Ginekol Pol 73:1061–1070PubMed Czekierdowski A, Smolen A, Bednarek W, Kotarski J (2002) Three dimensional sonography and 3-D power Doppler angiography in differentiation of adnexal tumors. Ginekol Pol 73:1061–1070PubMed
31.
Zurück zum Zitat Alcazar JL, Castillo G (2005) Comparison of 2-dimensional and 3-dimensional power-Doppler imaging in complex adnexal masses for the prediction of ovarian cancer. Am J Obstet Gynecol 192:807–812PubMedCrossRef Alcazar JL, Castillo G (2005) Comparison of 2-dimensional and 3-dimensional power-Doppler imaging in complex adnexal masses for the prediction of ovarian cancer. Am J Obstet Gynecol 192:807–812PubMedCrossRef
32.
Zurück zum Zitat Andreopoulou E, Andreopoluos D, Adamis K, et al. (2002) Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer. Anticancer Res 22:1903–1908PubMed Andreopoulou E, Andreopoluos D, Adamis K, et al. (2002) Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer. Anticancer Res 22:1903–1908PubMed
33.
Zurück zum Zitat Weidner N, Folkman J, Pozza F, et al. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 84:1875–1887PubMedCrossRef Weidner N, Folkman J, Pozza F, et al. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 84:1875–1887PubMedCrossRef
34.
Zurück zum Zitat Folkman J 1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6CrossRef Folkman J 1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6CrossRef
35.
Zurück zum Zitat Rak JW, St Croix DB, Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastatis and cancer therapy. Anticancer Drugs 6:3–18PubMedCrossRef Rak JW, St Croix DB, Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastatis and cancer therapy. Anticancer Drugs 6:3–18PubMedCrossRef
36.
Zurück zum Zitat Skobe M, Rockwell P, Vosseler S, Fusenig NE (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3:1222–1227PubMedCrossRef Skobe M, Rockwell P, Vosseler S, Fusenig NE (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3:1222–1227PubMedCrossRef
37.
Zurück zum Zitat Folkman J (1995) Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat Med 1:27–31PubMedCrossRef Folkman J (1995) Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat Med 1:27–31PubMedCrossRef
38.
Zurück zum Zitat Hanahan D, Folkman J (1996) Parameters and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–354PubMedCrossRef Hanahan D, Folkman J (1996) Parameters and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–354PubMedCrossRef
39.
Zurück zum Zitat Emoto M, Iwasaki H, Mimura K, et al. (1997) Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Cancel 80:899–907CrossRef Emoto M, Iwasaki H, Mimura K, et al. (1997) Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Cancel 80:899–907CrossRef
40.
Zurück zum Zitat Suren A, Osmers R, Kuhn W (1998) 3-D color power Angio™ imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 2:133–138CrossRef Suren A, Osmers R, Kuhn W (1998) 3-D color power Angio™ imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 2:133–138CrossRef
41.
Zurück zum Zitat Kupesic S, Kurjak A (2000) Contrast enhanced three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol 96:452–458PubMedCrossRef Kupesic S, Kurjak A (2000) Contrast enhanced three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol 96:452–458PubMedCrossRef
42.
Zurück zum Zitat Pairleitner H, Steiner H, Hasenoehrl G, Staudach A (1999) Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet GynecoL 14:139–143PubMedCrossRef Pairleitner H, Steiner H, Hasenoehrl G, Staudach A (1999) Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet GynecoL 14:139–143PubMedCrossRef
43.
Zurück zum Zitat Suren A, Osmers R, Kuhn W (1998) 3-D color power Angio™ imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 11:133–137PubMedCrossRef Suren A, Osmers R, Kuhn W (1998) 3-D color power Angio™ imaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 11:133–137PubMedCrossRef
44.
Zurück zum Zitat Kupesic S, Plavsic BM (2005) Three-dimensional power Doppler ultrasound in detection of early ovarian carcinoma. ECR, Vienna, Book Abstr 439 Kupesic S, Plavsic BM (2005) Three-dimensional power Doppler ultrasound in detection of early ovarian carcinoma. ECR, Vienna, Book Abstr 439
Metadaten
Titel
Early ovarian cancer: 3-D power Doppler
verfasst von
S. Kupesic
B. M. Plavsic
Publikationsdatum
01.10.2006
Erschienen in
Abdominal Radiology / Ausgabe 5/2006
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-005-0398-1

Weitere Artikel der Ausgabe 5/2006

Abdominal Radiology 5/2006 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.